Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Manufacturer savings programs Eli Lilly has not yet launched retatrutide commercially, so no manufacturer savings program currently exists
(B-D) Bar graphs summarize number of cells that are positive for (B) hrGFP, (C) Fos, and (D) both hrGFP and Fos
Phase 3 trials are underway through the TRIUMPH program
Those numbers tell a compelling story for agents who're willing to develop expertise in this specialized market
Weight Loss Medication Consumer Insights According to PwCs 2024 GLP-1 Trends and Impact survey, more than one in 10 Americans (around 14%) are currently taking a weight loss medication and nearly 35% have expressed interest in taking one
US$ 20.99
US$ 26.54
US$ 25.47
US$ 27.63
US$ 20.13
US$ 28.20
